Vertex Pharmaceuticals, Inc.
NASDAQ:VRTX
| Market Cap (Intraday) | 86.05B |
| Current PE | 26.40 |
| Forward PE | 22.96 |
| 2yr Forward PE | 21.04 |
| 10-Day MA | $331.48 |
| 50-Day MA | $333.40 |
| 200-Day MA | $307.79 |
Vertex Pharmaceuticals, Inc. Stock, NASDAQ:VRTX
50 Northern Avenue, Boston, Massachusetts 02210
United States of America
Phone: +1.617.341.6100
Number of Employees: 4800
Description
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.